+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cutaneous Mastocytosis Drug"

Cutaneous Mastocytosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Cutaneous Mastocytosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 213 Pages
  • Global
Cutaneous Mastocytosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Cutaneous Mastocytosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • November 2022
  • 119 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Cutaneous Mastocytosis (CM) is a rare skin disorder caused by an abnormal accumulation of mast cells in the skin. It is characterized by red-brown patches, plaques, or nodules on the skin. Treatment of CM is typically symptomatic, with the goal of reducing the symptoms of the disorder. Dermatological drugs used to treat CM include antihistamines, topical corticosteroids, and topical calcineurin inhibitors. In more severe cases, systemic medications such as cromolyn sodium, ketotifen, and hydroxyzine may be prescribed. In addition, phototherapy and laser therapy may be used to reduce the appearance of lesions. Companies in the Cutaneous Mastocytosis Drug market include Novartis, Pfizer, Sanofi, and Mylan. Show Less Read more